Literature DB >> 6398582

Macrophage interaction with mycobacteria including M. leprae.

A Ryter, C Frehel, N Rastogi, H L David.   

Abstract

Resistance properties of pathogenic mycobacteria to macrophage bactericidal activity seems to be due mostly to the composition and constitution of their cell walls. In the case of Mycobacterium tuberculosis, sulfatides and polyglutamic acid could be implicated in the phenomenon of fusion inhibition between phagosomes and lysosomes. M. leprae and M. lepraemurium, which do not seem to inhibit fusions are protected by a thick electron transparent zone (ETZ) that seems to be composed of mycosides. This layer would inhibit lysosomal enzyme diffusion inside phagosomes. As ETZ does not exist in mycobacteria before their phagocytosis, we have tried to see when and how it is formed inside macrophages. We have compared ETZ formation in M. leprae and M. avium which both contain mycosides. These two species were allowed to be phagocytized by mouse bone-marrow derived macrophage and samples were taken for electron microscopy during the first hours of phagocytosis and also during several weeks of incubation. In M. avium ETZ appeared within 1 to 2 hours after phagocytosis. It seems to be formed by a sort of swelling of the thin electron transparent layer of the bacterial cell wall. This swelling occurs only in regions where the external polysaccharide layer of M. avium starts to disappear. After 1 to 3 hours, this layer was completely absent and all bacteria were enveloped in a thick ETZ. In M. leprae, the ETZ is also formed within one hour after ingestion. However, the presence in some bacteria of a very thin dense layer located at the original place of the outer dense layer of the cell wall does not fit well with the idea of ETL swelling. In addition, the appearance of a thick dense layer located between the ETZ and the phagosome membrane is not yet understood. The ETZ formed also rapidly in macrophages infected with heat killed cells of M. avium or M. leprae. This shows that its formation does not require the active participation of the bacterium. As already proposed ETZ seems to lessen considerably the diffusion of lysosomal enzymes towards the bacterium in both species. In M. leprae it seems especially efficient because despite acid phosphatase activity found in many phagosomes, neither the number of bacteria per macrophage nor their state of degradation changed during 3 and a half months of macrophage culture.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1984        PMID: 6398582

Source DB:  PubMed          Journal:  Acta Leprol        ISSN: 0001-5938


  6 in total

1.  Mycobacterium leprae surface components intervene in the early phagosome-lysosome fusion inhibition event.

Authors:  C Frehel; N Rastogi
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

2.  Morphological aspects of the interaction of Bacillus Calmette-Guérin with urothelial bladder cells in vivo and in vitro: relevance for antitumor activity?

Authors:  J S Teppema; E C de Boer; P A Steerenberg; A P van der Meijden
Journal:  Urol Res       Date:  1992

3.  Interaction of Mycobacterium avium with environmental amoebae enhances virulence.

Authors:  J D Cirillo; S Falkow; L S Tompkins; L E Bermudez
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

4.  Evidence for inhibition of fusion of lysosomal and prelysosomal compartments with phagosomes in macrophages infected with pathogenic Mycobacterium avium.

Authors:  C Frehel; C de Chastellier; T Lang; N Rastogi
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

5.  Biofilm formation in the lung contributes to virulence and drug tolerance of Mycobacterium tuberculosis.

Authors:  Poushali Chakraborty; Sapna Bajeli; Deepak Kaushal; Bishan Dass Radotra; Ashwani Kumar
Journal:  Nat Commun       Date:  2021-03-11       Impact factor: 14.919

Review 6.  Bacillus anthracis factors for phagosomal escape.

Authors:  Fiorella Tonello; Irene Zornetta
Journal:  Toxins (Basel)       Date:  2012-07-10       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.